Author:
Choi Hyun-Myung,Jung Yunu,Park Jinbong,Kim Hye-Lin,Youn Dong-Hyun,Kang JongWook,Jeong Mi-Young,Lee Jong-Hyun,Yang Woong Mo,Lee Seok-Geun,Ahn Kwang Seok,Um Jae-Young
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Carson, C. 3rd & Rittmaster, R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 61, 2–7 (2003).
2. McVary, K. T. BPH: epidemiology and comorbidities. Am J Manag Care 12, S122–128 (2006).
3. Roehrborn, C. G. Benign prostatic hyperplasia: an overview. Rev Urol 7 Suppl 9, S3–S14 (2005).
4. Barkin, J. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Can J Urol 18 Suppl, 14–19 (2011).
5. Thigpen, A. E. et al. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92, 903–910, 10.1172/jci116665 (1993).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献